Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma

JAMA Surgery

Volumn 149, Issue 7, 2014, Pages 700-706

  Rossi, Carlo Riccardo ^a,b   Mozzillo, Nicola ^c   Maurichi, Andrea ^d   Pasquali, Sandro ^b   Macripò, Giuseppe ^e   Borgognoni, Lorenzo ^f   Solari, Nicola ^g   Piazzalunga, Dario ^h   Mascheroni, Luigi ⁱ   Giudice, Giuseppe ^j   Mocellin, Simone ^b   Patuzzo, Roberto ^d   Caracò, Corrado ^c   Ribero, Simone ^e   Marone, Ugo ^c   Santinami, Mario ^d  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h Riuniti Hospital   (Italy)

ⁱ HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^j UNIVERSITY OF BARI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CERVICAL LYMPH NODE; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; TERTIARY CARE CENTER;

ADULT; AGED; FEMALE; HUMANS; ITALY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84904394363     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.5676     Document Type: Article

References (38)

1. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433-441. (Pubitemid 47073566)
2. Gervasoni JE Jr, Sbayi S, Cady B. Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol. 2007;14(9):2443-2462. (Pubitemid 47389558)
3. Mariette C, Piessen G, Briez N, Triboulet JP. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247(2):365-371. (Pubitemid 351156783)
4. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23(28):7114-7124.
5. Tomlinson JS, Jain S, Bentrem DJ, et al. Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg. 2007;142(8):767-723.
6. Wong SL. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. JAMA. 2011;306(10):1139-1141.
7. Bilimoria KY, Raval MV, Bentrem DJ, Wayne JD, Balch CM, Ko CY. National assessment of melanoma care using formally developed quality indicators. J Clin Oncol. 2009;27(32):5445-5451.
8. Senthil M, Trisal V, Paz IB, Lai LL. Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch Surg. 2010;145(9):840-843.
9. Ostadi MA, Harnish JL, Stegienko S, Urbach DR. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc. 2007;21(12):2142-2146. (Pubitemid 350125964)
10. Balch CM, Gershenwald JE, Soong SJ, et al. Multivariable analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28(14):2452- 2459.
11. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622-3634. (Pubitemid 32786275)
12. Pasquali S, Mocellin S, Campana LG, et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature meta-analysis. Cancer. 2010;116(5):1201-1209.
13. Morton DL, Thompson JF, Cochran AJ, et al MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307-1317. (Pubitemid 44465459)
14. Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg. 1983;198(2):164-167. (Pubitemid 13027112)
15. Spillane AJ, Cheung BL, Stretch JR, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249(3):473-480.
16. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: cutaneous melanoma: version 1; 2013. http://www.nccn.org/ professionals/physician-gls/pdf/melanoma.pdf. Accessed May 10, 2013.
17. Pasquali S, Spillane AJ, deWilt JH, et al. Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey. Ann Surg Oncol. 2012;19(13):4322-4329.
18. Spillane AJ, Haydu L, McMillan W, Stretch JR, Thompson JF. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population. Ann Surg Oncol. 2011;18(9):2521-2528.
19. Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer. 2003;97(6):1488-1498. (Pubitemid 36297779)
20. Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol. 2004;11(4):426-433. (Pubitemid 40486754)
21. Basi Scientifiche Linee Guida. Documenti: melanoma cutaneo (2012). http://www.iss.it/lgac/docu/index.php?lang=1&tipo=32&area=110. Accessed March 24, 2014.
22. Xing Y, Badgwell BD, Ross MI, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115(11):2505-2513.
23. Multicenter Selective Lymphadenectomy Trial II (MSLT-II). http://clinicaltrial.gov/ct2/show/NCT00297895?term=MSLT+2&rank=2. Published February 27, 2006. Last updated December 27, 2013. Accessed January 29, 2012.
24. Eggermont AM, Suciu S, Santinami M, et al EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet. 2008;372(9633):117-126. (Pubitemid 351952257)
25. Galliot-Repkat C, Cailliod R, Trost O, et al. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Eur J Surg Oncol. 2006;32(7):790-794. (Pubitemid 44276007)
26. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008;100(18):1310-1317.
27. Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306(10):1089-1097.
28. Wong SL. Lymph node counts and survival rates after resection for colon and rectal cancer. Gastrointest Cancer Res. 2009;3(2)(suppl):S33-S35.
29. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149-2154. (Pubitemid 350106653)
30. Bilimoria KY, Stewart AK, Edge SB, Ko CY. Lymph node examination rate, survival rate, and quality of care in colon cancer. JAMA. 2008;299(8):896. doi:10.1001/jama.299.8.896-a. (Pubitemid 351397073)
31. Simunovic M, Baxter NN. Lymph node counts in colon cancer surgery: lessons for users of quality indicators. JAMA. 2007;298(18):2194-2195. (Pubitemid 350106659)
32. Spillane AJ, Haydu LE, Lee NC, et al. Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patients. Ann Surg Oncol. 2012;19(12):3919-3925.
33. Lee NC, Spillane AJ, Pang TC, Haydu LE, Uren RF. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients. Ann Surg Oncol. 2012;19(1):280-286.
34. Sondak VK. How do we know when a lymph node dissection is adequate? Ann Surg Oncol. 2011;18(9):2419-2421.
35. Rieger NA, Barnett FS, Moore JW, et al. Quality of pathology reporting impacts on lymph node yield in colon cancer. J Clin Oncol. 2007;25(4):463. doi:10.1200/JCO.2006.09.2304. (Pubitemid 350003005)
36. Compton CC; Cancer Committee. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Arch Pathol Lab Med. 2000;124(7):1016-1025.
37. Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ratio provides prognostic information in addition to American Joint Committee on Cancer N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg. 2011;253(1):109-115.
38. Spillane A, Allan C, Haydu L, Paton E. We need a trial to evaluate whether patients with involved inguinal lymph nodes should have inguinal or ilio-inguinal lymphadenectomy: an overview of the proposed trial ANZMTG 01.12. Paper presented at: EAGLE FM Protocol, Global Controversies and Advances in Skin Cancer; November 2013; Brisbane, Australia.